Funds and ETFs Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 16:00:02 2024-04-12 EDT 5-day change 1st Jan Change
125.7 USD -0.33% Intraday chart for Merck & Co., Inc. -1.76% +15.34%

ETFs positioned on Merck & Co., Inc.

Name Weight AuM 1st Jan change Investor Rating
14.34% 215 M€ +8.44% -
5.61% 18 M€ +5.81% -
2.85% 9 M€ -.--% -
2.80% 2 M€ -.--% -
2.63% 5 M€ -72.95% -
2.08% 8 M€ -.--%
1.96% 16 M€ -3.37%
1.96% 1 M€ +11.94% -
1.96% 3 M€ +7.32% -
1.96% 13 M€ -.--% -
1.95% 2 M€ +7.50%
1.91% 120 M€ +10.86% -
1.84% 487 M€ +4.08%
1.50% 9 M€ -4.31% -
1.43% 393 M€ +5.03%
1.40% 267 M€ +6.34%
1.35% 2 M€ +14.69% -
1.17% 13 M€ -.--% -
1.17% 4 M€ -.--% -
1.17% 3 M€ +15.16% -
1.13% 92 M€ +0.06% -
1.08% 10 M€ +5.34%
1.05% 36 M€ -.--%
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
125.7 USD
Average target price
137.2 USD
Spread / Average Target
+9.09%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Funds and ETFs Merck & Co., Inc.